Osaka, Japan

Masahiro Takamura

This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Sumitomo Pharma Co., Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Takamura. Retrieved from https://idiyas.com/inventor/masahiro-takamura-tvpfa4z0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masahiro Takamura: Innovator in Pharmaceutical Chemistry

Introduction

Masahiro Takamura is a prominent inventor based in Osaka, Japan. He is known for his significant contributions to pharmaceutical chemistry, particularly in the development of compounds aimed at treating schizophrenia and other central neurological diseases.

Latest Patents

Takamura holds a patent for an invention titled "N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof." This innovative compound demonstrates high effectiveness against positive symptoms, negative symptoms, and cognitive dysfunction associated with schizophrenia. It also aims to reduce the risks of conventional side effects while providing remarkable effects for other cognitive dysfunction-related neurological diseases.

Career Highlights

Takamura is affiliated with Dainippon Sumitomo Pharma Co., Ltd., where he has made significant strides in pharmaceutical research and development. His work focuses on creating effective treatments that enhance the quality of life for individuals suffering from mental health disorders.

Collaborations

Throughout his career, Takamura has collaborated with notable colleagues, including Megumi Maruyama and Naoya Kinomura. These partnerships have contributed to the advancement of innovative solutions in the pharmaceutical field.

Conclusion

Masahiro Takamura's work exemplifies the impact of innovation in the pharmaceutical industry. His dedication to developing effective treatments for schizophrenia and related conditions highlights the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…